Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.
LPI (LP Information)' newest research report, the "Rasagiline Tablet Industry Forecast" looks at past sales and reviews total world Rasagiline Tablet sales in 2022, providing a comprehensive analysis by region and market sector of projected Rasagiline Tablet sales for 2023 through 2029. With Rasagiline Tablet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rasagiline Tablet industry.
This Insight Report provides a comprehensive analysis of the global Rasagiline Tablet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rasagiline Tablet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rasagiline Tablet market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rasagiline Tablet and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rasagiline Tablet.
The global Rasagiline Tablet market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identified it as a potential drug for Parkinson's disease, and working with collaborators at Technion - Israel Institute of Technology in Israel and the drug company, Teva Pharmaceutical, identified the R-isomer as the active form of the drug. Teva brought it to market in partnership with Lundbeck in Europe and Eisai in the US and elsewhere. It was approved in Europe in 2005 and in the US in 2006.
This report presents a comprehensive overview, market shares, and growth opportunities of Rasagiline Tablet market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 0.5 mg/Pcs
- 1 mg/Pcs
Segmentation by application
- Under 40 Years Old
- 40-65 Years Old
- Above 65 Years Old
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Teva Pharmaceutical
- Lundbeck
- Sun Pharmaceutical
- Apotex
- Taj Pharma
- Mylan
- Takeda Pharmaceutical
- Sandoz
- Intas Pharmaceuticals
- Natco Pharma
- Ajanta Pharma
- Orchid Pharma
- Alkem Laboratories
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rasagiline Tablet market?
What factors are driving Rasagiline Tablet market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rasagiline Tablet market opportunities vary by end market size?
How does Rasagiline Tablet break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Global Rasagiline Tablet Market Growth 2023-2029
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rasagiline Tablet Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rasagiline Tablet by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rasagiline Tablet by Country/Region, 2018, 2022 & 2029
2.2 Rasagiline Tablet Segment by Type
2.2.1 0.5 mg/Pcs
2.2.2 1 mg/Pcs
2.3 Rasagiline Tablet Sales by Type
2.3.1 Global Rasagiline Tablet Sales Market Share by Type (2018-2023)
2.3.2 Global Rasagiline Tablet Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rasagiline Tablet Sale Price by Type (2018-2023)
2.4 Rasagiline Tablet Segment by Application
2.4.1 Under 40 Years Old
2.4.2 40-65 Years Old
2.4.3 Above 65 Years Old
2.5 Rasagiline Tablet Sales by Application
2.5.1 Global Rasagiline Tablet Sale Market Share by Application (2018-2023)
2.5.2 Global Rasagiline Tablet Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rasagiline Tablet Sale Price by Application (2018-2023)
3 Global Rasagiline Tablet by Company
3.1 Global Rasagiline Tablet Breakdown Data by Company
3.1.1 Global Rasagiline Tablet Annual Sales by Company (2018-2023)
3.1.2 Global Rasagiline Tablet Sales Market Share by Company (2018-2023)
3.2 Global Rasagiline Tablet Annual Revenue by Company (2018-2023)
3.2.1 Global Rasagiline Tablet Revenue by Company (2018-2023)
3.2.2 Global Rasagiline Tablet Revenue Market Share by Company (2018-2023)
3.3 Global Rasagiline Tablet Sale Price by Company
3.4 Key Manufacturers Rasagiline Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rasagiline Tablet Product Location Distribution
3.4.2 Players Rasagiline Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rasagiline Tablet by Geographic Region
4.1 World Historic Rasagiline Tablet Market Size by Geographic Region (2018-2023)
4.1.1 Global Rasagiline Tablet Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rasagiline Tablet Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rasagiline Tablet Market Size by Country/Region (2018-2023)
4.2.1 Global Rasagiline Tablet Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rasagiline Tablet Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rasagiline Tablet Sales Growth
4.4 APAC Rasagiline Tablet Sales Growth
4.5 Europe Rasagiline Tablet Sales Growth
4.6 Middle East & Africa Rasagiline Tablet Sales Growth
5 Americas
5.1 Americas Rasagiline Tablet Sales by Country
5.1.1 Americas Rasagiline Tablet Sales by Country (2018-2023)
5.1.2 Americas Rasagiline Tablet Revenue by Country (2018-2023)
5.2 Americas Rasagiline Tablet Sales by Type
5.3 Americas Rasagiline Tablet Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rasagiline Tablet Sales by Region
6.1.1 APAC Rasagiline Tablet Sales by Region (2018-2023)
6.1.2 APAC Rasagiline Tablet Revenue by Region (2018-2023)
6.2 APAC Rasagiline Tablet Sales by Type
6.3 APAC Rasagiline Tablet Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rasagiline Tablet by Country
7.1.1 Europe Rasagiline Tablet Sales by Country (2018-2023)
7.1.2 Europe Rasagiline Tablet Revenue by Country (2018-2023)
7.2 Europe Rasagiline Tablet Sales by Type
7.3 Europe Rasagiline Tablet Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rasagiline Tablet by Country
8.1.1 Middle East & Africa Rasagiline Tablet Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rasagiline Tablet Revenue by Country (2018-2023)
8.2 Middle East & Africa Rasagiline Tablet Sales by Type
8.3 Middle East & Africa Rasagiline Tablet Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rasagiline Tablet
10.3 Manufacturing Process Analysis of Rasagiline Tablet
10.4 Industry Chain Structure of Rasagiline Tablet
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rasagiline Tablet Distributors
11.3 Rasagiline Tablet Customer
12 World Forecast Review for Rasagiline Tablet by Geographic Region
12.1 Global Rasagiline Tablet Market Size Forecast by Region
12.1.1 Global Rasagiline Tablet Forecast by Region (2024-2029)
12.1.2 Global Rasagiline Tablet Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rasagiline Tablet Forecast by Type
12.7 Global Rasagiline Tablet Forecast by Application
13 Key Players Analysis
13.1 Teva Pharmaceutical
13.1.1 Teva Pharmaceutical Company Information
13.1.2 Teva Pharmaceutical Rasagiline Tablet Product Portfolios and Specifications
13.1.3 Teva Pharmaceutical Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Pharmaceutical Main Business Overview
13.1.5 Teva Pharmaceutical Latest Developments
13.2 Lundbeck
13.2.1 Lundbeck Company Information
13.2.2 Lundbeck Rasagiline Tablet Product Portfolios and Specifications
13.2.3 Lundbeck Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Lundbeck Main Business Overview
13.2.5 Lundbeck Latest Developments
13.3 Sun Pharmaceutical
13.3.1 Sun Pharmaceutical Company Information
13.3.2 Sun Pharmaceutical Rasagiline Tablet Product Portfolios and Specifications
13.3.3 Sun Pharmaceutical Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sun Pharmaceutical Main Business Overview
13.3.5 Sun Pharmaceutical Latest Developments
13.4 Apotex
13.4.1 Apotex Company Information
13.4.2 Apotex Rasagiline Tablet Product Portfolios and Specifications
13.4.3 Apotex Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Apotex Main Business Overview
13.4.5 Apotex Latest Developments
13.5 Taj Pharma
13.5.1 Taj Pharma Company Information
13.5.2 Taj Pharma Rasagiline Tablet Product Portfolios and Specifications
13.5.3 Taj Pharma Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Taj Pharma Main Business Overview
13.5.5 Taj Pharma Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Rasagiline Tablet Product Portfolios and Specifications
13.6.3 Mylan Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Information
13.7.2 Takeda Pharmaceutical Rasagiline Tablet Product Portfolios and Specifications
13.7.3 Takeda Pharmaceutical Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Takeda Pharmaceutical Main Business Overview
13.7.5 Takeda Pharmaceutical Latest Developments
13.8 Sandoz
13.8.1 Sandoz Company Information
13.8.2 Sandoz Rasagiline Tablet Product Portfolios and Specifications
13.8.3 Sandoz Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sandoz Main Business Overview
13.8.5 Sandoz Latest Developments
13.9 Intas Pharmaceuticals
13.9.1 Intas Pharmaceuticals Company Information
13.9.2 Intas Pharmaceuticals Rasagiline Tablet Product Portfolios and Specifications
13.9.3 Intas Pharmaceuticals Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Intas Pharmaceuticals Main Business Overview
13.9.5 Intas Pharmaceuticals Latest Developments
13.10 Natco Pharma
13.10.1 Natco Pharma Company Information
13.10.2 Natco Pharma Rasagiline Tablet Product Portfolios and Specifications
13.10.3 Natco Pharma Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Natco Pharma Main Business Overview
13.10.5 Natco Pharma Latest Developments
13.11 Ajanta Pharma
13.11.1 Ajanta Pharma Company Information
13.11.2 Ajanta Pharma Rasagiline Tablet Product Portfolios and Specifications
13.11.3 Ajanta Pharma Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Ajanta Pharma Main Business Overview
13.11.5 Ajanta Pharma Latest Developments
13.12 Orchid Pharma
13.12.1 Orchid Pharma Company Information
13.12.2 Orchid Pharma Rasagiline Tablet Product Portfolios and Specifications
13.12.3 Orchid Pharma Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Orchid Pharma Main Business Overview
13.12.5 Orchid Pharma Latest Developments
13.13 Alkem Laboratories
13.13.1 Alkem Laboratories Company Information
13.13.2 Alkem Laboratories Rasagiline Tablet Product Portfolios and Specifications
13.13.3 Alkem Laboratories Rasagiline Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Alkem Laboratories Main Business Overview
13.13.5 Alkem Laboratories Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Rasagiline Tablet Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rasagiline Tablet Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 0.5 mg/Pcs
Table 4. Major Players of 1 mg/Pcs
Table 5. Global Rasagiline Tablet Sales by Type (2018-2023) & (M Pcs)
Table 6. Global Rasagiline Tablet Sales Market Share by Type (2018-2023)
Table 7. Global Rasagiline Tablet Revenue by Type (2018-2023) & ($ million)
Table 8. Global Rasagiline Tablet Revenue Market Share by Type (2018-2023)
Table 9. Global Rasagiline Tablet Sale Price by Type (2018-2023) & (USD/K Pcs)
Table 10. Global Rasagiline Tablet Sales by Application (2018-2023) & (M Pcs)
Table 11. Global Rasagiline Tablet Sales Market Share by Application (2018-2023)
Table 12. Global Rasagiline Tablet Revenue by Application (2018-2023)
Table 13. Global Rasagiline Tablet Revenue Market Share by Application (2018-2023)
Table 14. Global Rasagiline Tablet Sale Price by Application (2018-2023) & (USD/K Pcs)
Table 15. Global Rasagiline Tablet Sales by Company (2018-2023) & (M Pcs)
Table 16. Global Rasagiline Tablet Sales Market Share by Company (2018-2023)
Table 17. Global Rasagiline Tablet Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Rasagiline Tablet Revenue Market Share by Company (2018-2023)
Table 19. Global Rasagiline Tablet Sale Price by Company (2018-2023) & (USD/K Pcs)
Table 20. Key Manufacturers Rasagiline Tablet Producing Area Distribution and Sales Area
Table 21. Players Rasagiline Tablet Products Offered
Table 22. Rasagiline Tablet Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rasagiline Tablet Sales by Geographic Region (2018-2023) & (M Pcs)
Table 26. Global Rasagiline Tablet Sales Market Share Geographic Region (2018-2023)
Table 27. Global Rasagiline Tablet Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Rasagiline Tablet Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Rasagiline Tablet Sales by Country/Region (2018-2023) & (M Pcs)
Table 30. Global Rasagiline Tablet Sales Market Share by Country/Region (2018-2023)
Table 31. Global Rasagiline Tablet Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Rasagiline Tablet Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 34. Americas Rasagiline Tablet Sales Market Share by Country (2018-2023)
Table 35. Americas Rasagiline Tablet Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Rasagiline Tablet Revenue Market Share by Country (2018-2023)
Table 37. Americas Rasagiline Tablet Sales by Type (2018-2023) & (M Pcs)
Table 38. Americas Rasagiline Tablet Sales by Application (2018-2023) & (M Pcs)
Table 39. APAC Rasagiline Tablet Sales by Region (2018-2023) & (M Pcs)
Table 40. APAC Rasagiline Tablet Sales Market Share by Region (2018-2023)
Table 41. APAC Rasagiline Tablet Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Rasagiline Tablet Revenue Market Share by Region (2018-2023)
Table 43. APAC Rasagiline Tablet Sales by Type (2018-2023) & (M Pcs)
Table 44. APAC Rasagiline Tablet Sales by Application (2018-2023) & (M Pcs)
Table 45. Europe Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 46. Europe Rasagiline Tablet Sales Market Share by Country (2018-2023)
Table 47. Europe Rasagiline Tablet Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Rasagiline Tablet Revenue Market Share by Country (2018-2023)
Table 49. Europe Rasagiline Tablet Sales by Type (2018-2023) & (M Pcs)
Table 50. Europe Rasagiline Tablet Sales by Application (2018-2023) & (M Pcs)
Table 51. Middle East & Africa Rasagiline Tablet Sales by Country (2018-2023) & (M Pcs)
Table 52. Middle East & Africa Rasagiline Tablet Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Rasagiline Tablet Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Rasagiline Tablet Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rasagiline Tablet Sales by Type (2018-2023) & (M Pcs)
Table 56. Middle East & Africa Rasagiline Tablet Sales by Application (2018-2023) & (M Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Rasagiline Tablet
Table 58. Key Market Challenges & Risks of Rasagiline Tablet
Table 59. Key Industry Trends of Rasagiline Tablet
Table 60. Rasagiline Tablet Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Rasagiline Tablet Distributors List
Table 63. Rasagiline Tablet Customer List
Table 64. Global Rasagiline Tablet Sales Forecast by Region (2024-2029) & (M Pcs)
Table 65. Global Rasagiline Tablet Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Rasagiline Tablet Sales Forecast by Country (2024-2029) & (M Pcs)
Table 67. Americas Rasagiline Tablet Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Rasagiline Tablet Sales Forecast by Region (2024-2029) & (M Pcs)
Table 69. APAC Rasagiline Tablet Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Rasagiline Tablet Sales Forecast by Country (2024-2029) & (M Pcs)
Table 71. Europe Rasagiline Tablet Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Rasagiline Tablet Sales Forecast by Country (2024-2029) & (M Pcs)
Table 73. Middle East & Africa Rasagiline Tablet Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Rasagiline Tablet Sales Forecast by Type (2024-2029) & (M Pcs)
Table 75. Global Rasagiline Tablet Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Rasagiline Tablet Sales Forecast by Application (2024-2029) & (M Pcs)
Table 77. Global Rasagiline Tablet Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Teva Pharmaceutical Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Pharmaceutical Rasagiline Tablet Product Portfolios and Specifications
Table 80. Teva Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 81. Teva Pharmaceutical Main Business
Table 82. Teva Pharmaceutical Latest Developments
Table 83. Lundbeck Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 84. Lundbeck Rasagiline Tablet Product Portfolios and Specifications
Table 85. Lundbeck Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 86. Lundbeck Main Business
Table 87. Lundbeck Latest Developments
Table 88. Sun Pharmaceutical Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 89. Sun Pharmaceutical Rasagiline Tablet Product Portfolios and Specifications
Table 90. Sun Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 91. Sun Pharmaceutical Main Business
Table 92. Sun Pharmaceutical Latest Developments
Table 93. Apotex Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 94. Apotex Rasagiline Tablet Product Portfolios and Specifications
Table 95. Apotex Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 96. Apotex Main Business
Table 97. Apotex Latest Developments
Table 98. Taj Pharma Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 99. Taj Pharma Rasagiline Tablet Product Portfolios and Specifications
Table 100. Taj Pharma Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 101. Taj Pharma Main Business
Table 102. Taj Pharma Latest Developments
Table 103. Mylan Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Rasagiline Tablet Product Portfolios and Specifications
Table 105. Mylan Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 106. Mylan Main Business
Table 107. Mylan Latest Developments
Table 108. Takeda Pharmaceutical Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 109. Takeda Pharmaceutical Rasagiline Tablet Product Portfolios and Specifications
Table 110. Takeda Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 111. Takeda Pharmaceutical Main Business
Table 112. Takeda Pharmaceutical Latest Developments
Table 113. Sandoz Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 114. Sandoz Rasagiline Tablet Product Portfolios and Specifications
Table 115. Sandoz Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 116. Sandoz Main Business
Table 117. Sandoz Latest Developments
Table 118. Intas Pharmaceuticals Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 119. Intas Pharmaceuticals Rasagiline Tablet Product Portfolios and Specifications
Table 120. Intas Pharmaceuticals Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 121. Intas Pharmaceuticals Main Business
Table 122. Intas Pharmaceuticals Latest Developments
Table 123. Natco Pharma Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 124. Natco Pharma Rasagiline Tablet Product Portfolios and Specifications
Table 125. Natco Pharma Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 126. Natco Pharma Main Business
Table 127. Natco Pharma Latest Developments
Table 128. Ajanta Pharma Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 129. Ajanta Pharma Rasagiline Tablet Product Portfolios and Specifications
Table 130. Ajanta Pharma Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 131. Ajanta Pharma Main Business
Table 132. Ajanta Pharma Latest Developments
Table 133. Orchid Pharma Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 134. Orchid Pharma Rasagiline Tablet Product Portfolios and Specifications
Table 135. Orchid Pharma Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 136. Orchid Pharma Main Business
Table 137. Orchid Pharma Latest Developments
Table 138. Alkem Laboratories Basic Information, Rasagiline Tablet Manufacturing Base, Sales Area and Its Competitors
Table 139. Alkem Laboratories Rasagiline Tablet Product Portfolios and Specifications
Table 140. Alkem Laboratories Rasagiline Tablet Sales (M Pcs), Revenue ($ Million), Price (USD/K Pcs) and Gross Margin (2018-2023)
Table 141. Alkem Laboratories Main Business
Table 142. Alkem Laboratories Latest Developments
List of Figures
Figure 1. Picture of Rasagiline Tablet
Figure 2. Rasagiline Tablet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rasagiline Tablet Sales Growth Rate 2018-2029 (M Pcs)
Figure 7. Global Rasagiline Tablet Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rasagiline Tablet Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 0.5 mg/Pcs
Figure 10. Product Picture of 1 mg/Pcs
Figure 11. Global Rasagiline Tablet Sales Market Share by Type in 2022
Figure 12. Global Rasagiline Tablet Revenue Market Share by Type (2018-2023)
Figure 13. Rasagiline Tablet Consumed in Under 40 Years Old
Figure 14. Global Rasagiline Tablet Market: Under 40 Years Old (2018-2023) & (M Pcs)
Figure 15. Rasagiline Tablet Consumed in 40-65 Years Old
Figure 16. Global Rasagiline Tablet Market: 40-65 Years Old (2018-2023) & (M Pcs)
Figure 17. Rasagiline Tablet Consumed in Above 65 Years Old
Figure 18. Global Rasagiline Tablet Market: Above 65 Years Old (2018-2023) & (M Pcs)
Figure 19. Global Rasagiline Tablet Sales Market Share by Application (2022)
Figure 20. Global Rasagiline Tablet Revenue Market Share by Application in 2022
Figure 21. Rasagiline Tablet Sales Market by Company in 2022 (M Pcs)
Figure 22. Global Rasagiline Tablet Sales Market Share by Company in 2022
Figure 23. Rasagiline Tablet Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Rasagiline Tablet Revenue Market Share by Company in 2022
Figure 25. Global Rasagiline Tablet Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Rasagiline Tablet Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Rasagiline Tablet Sales 2018-2023 (M Pcs)
Figure 28. Americas Rasagiline Tablet Revenue 2018-2023 ($ Millions)
Figure 29. APAC Rasagiline Tablet Sales 2018-2023 (M Pcs)
Figure 30. APAC Rasagiline Tablet Revenue 2018-2023 ($ Millions)
Figure 31. Europe Rasagiline Tablet Sales 2018-2023 (M Pcs)
Figure 32. Europe Rasagiline Tablet Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Rasagiline Tablet Sales 2018-2023 (M Pcs)
Figure 34. Middle East & Africa Rasagiline Tablet Revenue 2018-2023 ($ Millions)
Figure 35. Americas Rasagiline Tablet Sales Market Share by Country in 2022
Figure 36. Americas Rasagiline Tablet Revenue Market Share by Country in 2022
Figure 37. Americas Rasagiline Tablet Sales Market Share by Type (2018-2023)
Figure 38. Americas Rasagiline Tablet Sales Market Share by Application (2018-2023)
Figure 39. United States Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Rasagiline Tablet Sales Market Share by Region in 2022
Figure 44. APAC Rasagiline Tablet Revenue Market Share by Regions in 2022
Figure 45. APAC Rasagiline Tablet Sales Market Share by Type (2018-2023)
Figure 46. APAC Rasagiline Tablet Sales Market Share by Application (2018-2023)
Figure 47. China Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Rasagiline Tablet Sales Market Share by Country in 2022
Figure 55. Europe Rasagiline Tablet Revenue Market Share by Country in 2022
Figure 56. Europe Rasagiline Tablet Sales Market Share by Type (2018-2023)
Figure 57. Europe Rasagiline Tablet Sales Market Share by Application (2018-2023)
Figure 58. Germany Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Rasagiline Tablet Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Rasagiline Tablet Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Rasagiline Tablet Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Rasagiline Tablet Sales Market Share by Application (2018-2023)
Figure 67. Egypt Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Rasagiline Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Rasagiline Tablet in 2022
Figure 73. Manufacturing Process Analysis of Rasagiline Tablet
Figure 74. Industry Chain Structure of Rasagiline Tablet
Figure 75. Channels of Distribution
Figure 76. Global Rasagiline Tablet Sales Market Forecast by Region (2024-2029)
Figure 77. Global Rasagiline Tablet Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Rasagiline Tablet Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Rasagiline Tablet Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Rasagiline Tablet Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Rasagiline Tablet Revenue Market Share Forecast by Application (2024-2029)
Global Parkinson's Disease Therapeutics Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 99
Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
Global Amantadine Hydrochloride Market Insights, Forecast to 2029
Published: 29-Aug-2023 Price: US 4900 Onwards Pages: 109
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
Global Rasagiline Tablet Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 107
Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.
The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
Global Parkinsons Disease Drug Market Insights, Forecast to 2029
Published: 02-Aug-2023 Price: US 4900 Onwards Pages: 113
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Global P......
Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 2680 Onwards Pages: 137
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 3280 Onwards Pages: 109
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Amantadine Hydrochloride Market Research Report 2023
Published: 09-Mar-2023 Price: US 2900 Onwards Pages: 98
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
Highlights
The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Amantadine hydrochloride is clinically effective......
Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 3280 Onwards Pages: 133
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 2680 Onwards Pages: 159
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
